SCHEMBL21723705

SCHEMBL21723705

COc1ccc(-c2cc3c(ccc(=O)n3C)s2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.51
RAB9A P51151 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
ALDH1A1 P00352 5/20 0.51
HPGD P15428 4/20 0.51
MAPT P10636 4/20 0.51
TP53 P04637 3/20 0.51
HSD17B10 Q99714 3/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
MAPK1 P28482 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
HDAC6 Q9UBN7 1/20 0.45
APP P05067 3/20 0.45
IKBKB O14920 2/20 0.43
PRKDC P78527 1/20 0.42
KDM4E B2RXH2 5/20 0.41
PKM P14618 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21723941 0.82 HSD17B10 (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL21723987 0.78 NPC1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL21723989 0.78 NPC1 (0.48) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL21723993 0.77 ALDH1A1 (0.38) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL23452001 0.74 LMNA (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL21723639 0.74 HSD17B10 (0.47) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL23451957 0.73 GABRG2 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL4614424 0.72 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL31457649 0.72 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL21723934 0.71 NPC1 (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415813-B2 Method for synthesizing thieno[3,2-b]pyridine-5(4H)-one derivative compound, using gold catalyst, and use therefor KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2025-09-16 US disclosed
WO-2023120800-A1 FLUORESCENT PROBE FOR DETECTING F-ACTIN AND USE THEREOF 한국해양과학기술원 2023-06-29 WO disclosed
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY 2022-04-19 US disclosed
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY 2022-04-19 US disclosed
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KP) 2021-10-28 US disclosed
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KP) 2021-10-28 US disclosed
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2021-06-10 US disclosed
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY (KR) 2021-06-10 US disclosed
WO-2020036243-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR 한국해양과학기술원 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332063-A1 METHOD FOR SYNTHESIZING THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, USING GOLD CATALYST, AND USE THEREFOR FARS2, CYP4F11, CYP4B1 NPC1 3352/4885RAB9A 3000/4885SMN1; SMN2 4636/4885
US-12415813-B2 Method for synthesizing thieno[3,2-b]pyridine-5(4H)-one derivative compound, using gold catalyst, and use therefor FARS2, CYP4F11, CYP4B1 NPC1 3352/4885RAB9A 3000/4885SMN1; SMN2 4636/4885
US-20210171539-A1 NOVEL THIENO[3,2-B]PYRIDINE-5(4H)-ONE DERIVATIVE COMPOUND, PREPARATION METHOD THEREOF AND USE THEREOF BRD4, BRPF3, AFF4 NPC1 4239/4885RAB9A 4070/4885SMN1; SMN2 4333/4885
US-11306103-B2 Thieno[3,2-b]pyridine-5(4H)-one derivative compound, preparation method thereof and use thereof BRD4, BRPF3, AFF4 NPC1 4212/4885RAB9A 4124/4885SMN1; SMN2 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.